M&A Deal Summary |
|
---|---|
Date | 2015-08-17 |
Target | Cord Blood Registry |
Sector | Healthcare Services |
Buyer(s) | AMAG Pharmaceuticals |
Sellers(s) | GTCR |
Deal Type | Add-on Acquisition |
Deal Value | 700M USD |
Advisor(s) | Houlihan Lokey (Financial) Kirkland & Ellis (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1981 |
Sector | Life Science |
Employees | 440 |
Revenue | 328M USD (2019) |
AMAG Pharmaceuticals, Inc. is a specialty pharmaceutical company that markets Feraheme (ferumoxytol) Injection and MuGard® Mucoadhesive Oral Wound Rinse. AMAG Pharmaceuticals was formed in 1981 and is based in Waltham, Massachusetts.
DEAL STATS | # |
---|---|
Overall | 2 of 3 |
Sector (Healthcare Services) | 1 of 1 |
Type (Add-on Acquisition) | 2 of 3 |
State (California) | 1 of 1 |
Country (United States) | 2 of 3 |
Year (2015) | 1 of 1 |
Size (of disclosed) | 1 of 2 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2014-09-29 |
Lumara Health
St. Louis, Montana, United States Lumara Health, Inc. is a pharmaceutical company committed to advancing the health of women throughout the stages of their lives, with a particular focus on maternal health. |
Buy | $675M |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2018-12-13 |
Perosphere Pharmaceuticals
Danbury, Connecticut, United States Perosphere Pharmaceuticals, Inc. is a private clinical-stage company focused on developing rescue drugs. Perosphere Pharma's lead investigational drug product candidate, ciraparantag (PER977), is an FDA Fast Track designated, intravenously administered small synthetic water-soluble new molecular entity intended for use as a reversal agent for the orally administered direct Factor Xa inhibitors and low molecular weight heparin. |
Buy | - |
Category | Private Equity Firm |
---|---|
Founded | 1980 |
PE ASSETS | 15.0B USD |
Size | Mega |
Type | Sector Agnostic |
GTCR is a private equity firm that typically partners with management when pursuing acquisitions. The Firm looks to grow companies through build-on acquisitions, consolidations, and internal growth. GTCR will consider both equity and mezzanine capital commitments and concentrates its investment activity in consumer products & services, healthcare services, outsourced business services, technology, transaction processing, and pharma/medical products. GTCR was formed in 1980 and is based in Chicago, Illinois.
DEAL STATS | # |
---|---|
Overall | 52 of 84 |
Sector (Healthcare Services) | 11 of 16 |
Type (Add-on Acquisition) | 28 of 40 |
State (California) | 3 of 8 |
Country (United States) | 50 of 81 |
Year (2015) | 5 of 9 |
Size (of disclosed) | 19 of 33 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2015-07-27 |
Capella Healthcare
Franklin, Tennessee, United States Capella Healthcare is a provider of healthcare services. Capella Healthcare is based in Franklin, Tennessee. |
Sell | $900M |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2015-10-01 |
Aligned Asset Managers
Stamford, Connecticut, United States Aligned Asset Managers, headquartered in Stamford, CT, is a financial services holding company that specializes in making substantial equity investments in traditional and alternative investment firms. |
Sell | - |